UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006063
Receipt number R000007147
Scientific Title The effect of single tablet of fix-dose amlodipine and atorvastatin on blood pressure, lipid profile, and endothelium dependent relaxation of people with type 2 diabetes mellitus
Date of disclosure of the study information 2011/07/28
Last modified on 2012/08/29 15:02:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of single tablet of fix-dose amlodipine and atorvastatin on blood pressure, lipid profile, and endothelium dependent relaxation of people with type 2 diabetes mellitus

Acronym

The effect of single tablet of fix-dose amlodipine and atorvastatin on blood pressure, lipid profile, and endothelium dependent relaxation of people with type 2 diabetes mellitus

Scientific Title

The effect of single tablet of fix-dose amlodipine and atorvastatin on blood pressure, lipid profile, and endothelium dependent relaxation of people with type 2 diabetes mellitus

Scientific Title:Acronym

The effect of single tablet of fix-dose amlodipine and atorvastatin on blood pressure, lipid profile, and endothelium dependent relaxation of people with type 2 diabetes mellitus

Region

Japan


Condition

Condition

Type 2 diabetes mellitus
hypertension
dyslipidemia

Classification by specialty

Medicine in general Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of single-pill amlodipin/atrovastatin of endothelium dependent relaxation, blood pressure and lipid profiles in people with type 2 diabetes treatmented by Ca blocker and statin.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase IV


Assessment

Primary outcomes

the effect of single-pill amlodipin/atrovastatin upon FMD between baseline and after 3 months

Key secondary outcomes

Changes in the following items

blood pressure
lipid profiles (Total cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglyceride, Malondialdehyde-modified low-density lipoprotein)
Fasting blood glucose, HbA1c, GA
Intima-Media Thickness (IMT)
eGFR, urinary albumin excretion
Questionnaire about medication adherance
Adverse effect


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of single-pill of fixed dose amlodipin (5mg) and atorvatatin (10mg)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. people whose written imformed consent was obtained
2. people with type 2 diabetes mellitus complicated with hypertension and dyslipidemia
3. people were treated with amlodipin and any kind of statin except Atrovastatin for 3 months

Key exclusion criteria

1. the onset of ischemic heart disease (IHD) or stroke within 3 months
2. severe renal failure(Cr > 1.5mg/dl) and liver injury (AST and/or ALT > 100IU/dL)
3. pregnancy
4. Severe health problems not suitable for the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Bando Hiroyuki

Organization

FukuiKen Saiseikai Hospital

Division name

internal medicine

Zip code


Address

Funahashi Wadanaka 7-1, Fukui, Fukui, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

FukuiKen Saiseikai Hospital

Division name

internal medicine

Zip code


Address

Funahashi Wadanaka 7-1, Fukui, Fukui, Japan

TEL

0776231111

Homepage URL


Email

shimaccyo@gmial.com


Sponsor or person

Institute

FukuiKen Saiseikai Hospital

Institute

Department

Personal name



Funding Source

Organization

no source of funding

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 07 Month 28 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 03 Month 01 Day

Last follow-up date

2012 Year 05 Month 15 Day

Date of closure to data entry

2012 Year 05 Month 31 Day

Date trial data considered complete

2012 Year 05 Month 31 Day

Date analysis concluded

2012 Year 07 Month 31 Day


Other

Other related information



Management information

Registered date

2011 Year 07 Month 28 Day

Last modified on

2012 Year 08 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007147


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name